Slingshot members are tracking this event:
Lipocine (LPCN) receives FDA CRL for the 2nd time regarding its refiled MA for testosterone replacement therapy candidate Tlando
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Nov 11, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Testosterone Replacement Therapy, Tlando